Third quarter report-- The report is very positive. But one paragraph is very intriguing . I will quote it: The Company also continued to make substantial progress to increase production of CBD and a yet-to-be-disclosed cannabinoid through application of its proprietary strain engineering technologies. In-house strain and process optimization will continue through 2020 with scale-up development starting in early 2021. A "yet to be disclosed cannabinoid"...!!! I find thos fascinating as it reveals they have some very exciting news to share in the near future